Literature DB >> 35348065

Three Learning Organizations in Cataract Surgery: The Example of Intracameral Antibiotic Injection.

Neal H Shorstein1, Per Montan2, Aravind Haripriya3, Mats Lundström4, Lisa Herrinton5.   

Abstract

BACKGROUND: The recent systematic adoption of intracameral antibiotic injection during cataract surgery in Sweden, India, and the US serves as a model for the successful transitioning of local quality improvement initiatives to organization-wide implementation. Although the delivery of eye care in the 3 countries is distinctly organized with differing governances and technological infrastructure, each contains elements of a learning organization (ie, an organization that has adopted a culture of creating, acquiring, and transferring knowledge into practice through system-level and clinician-level change).
METHODS: We describe a retrospective and organizational implementation study of intracameral antibiotic injection in Sweden, through the efforts of the National Cataract Registry; in the US by Kaiser Permanente; and in India by the Aravind Eye Hospital System. Leadership structure, training in problem solving, benchmarking, sharing of technical knowledge, and data and workforce engagement are compared.
RESULTS: Each of the 3 organizations share the key elements of effective leadership, which values the exchange of ideas in the workforce, training and resourcing for change, and information management in the form of benchmarking and data sharing. In the case of intracameral antibiotic injection, a new technique was identified to improve quality and safety with a reduction in infections as evidence of the success of the programs.
CONCLUSION: Committing to a culture of collective learning, and leveraging each stakeholder's personal investment, health-care systems may improve care delivery and set new benchmarks in quality and safety.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 35348065      PMCID: PMC8822932          DOI: 10.7812/TPP/20.274

Source DB:  PubMed          Journal:  Perm J        ISSN: 1552-5767


  21 in total

1.  Kaiser Permanente's performance improvement system, Part 4: Creating a learning organization.

Authors:  Lisa Schilling; James W Dearing; Paul Staley; Patti Harvey; Linda Fahey; Francesca Kuruppu
Journal:  Jt Comm J Qual Patient Saf       Date:  2011-12

2.  Cost-effectiveness analysis of intracameral cefuroxime use for prophylaxis of endophthalmitis after cataract surgery.

Authors:  Emile Sharifi; Travis C Porco; Ayman Naseri
Journal:  Ophthalmology       Date:  2009-06-28       Impact factor: 12.079

Review 3.  Clinical Registries in Ophthalmology.

Authors:  Jeremy C K Tan; Alexander C Ferdi; Mark C Gillies; Stephanie L Watson
Journal:  Ophthalmology       Date:  2018-12-17       Impact factor: 12.079

4.  Prophylactic intracameral cefuroxime. Efficacy in preventing endophthalmitis after cataract surgery.

Authors:  Per G Montan; Gisela Wejde; Gabor Koranyi; Margareta Rylander
Journal:  J Cataract Refract Surg       Date:  2002-06       Impact factor: 3.351

5.  Decreased postoperative endophthalmitis rate after institution of intracameral antibiotics in a Northern California eye department.

Authors:  Neal H Shorstein; Kevin L Winthrop; Lisa J Herrinton
Journal:  J Cataract Refract Surg       Date:  2012-10-02       Impact factor: 3.351

6.  Endophthalmitis reduction with intracameral moxifloxacin in eyes with and without surgical complications: Results from 2 million consecutive cataract surgeries.

Authors:  Aravind Haripriya; David F Chang; Ravilla D Ravindran
Journal:  J Cataract Refract Surg       Date:  2019-07-29       Impact factor: 3.351

7.  Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors.

Authors: 
Journal:  J Cataract Refract Surg       Date:  2007-06       Impact factor: 3.351

8.  Efficacy of Intracameral Moxifloxacin Endophthalmitis Prophylaxis at Aravind Eye Hospital.

Authors:  Aravind Haripriya; David F Chang; Sathvik Namburar; Anand Smita; Ravilla D Ravindran
Journal:  Ophthalmology       Date:  2015-10-30       Impact factor: 12.079

9.  Intracameral moxifloxacin for endophthalmitis prophylaxis after cataract surgery: Cost-effectiveness analysis.

Authors:  Ella H Leung; Allister Gibbons; J Timothy Stout; Douglas D Koch
Journal:  J Cataract Refract Surg       Date:  2018-07-23       Impact factor: 3.351

10.  An updated estimate of costs of endophthalmitis following cataract surgery among Medicare patients: 2010-2014.

Authors:  Jordana K Schmier; Carolyn K Hulme-Lowe; David W Covert; Edmund C Lau
Journal:  Clin Ophthalmol       Date:  2016-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.